- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.63%
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
- 100 SMA
- 200 SMA
- 300 SMA
- 400 SMA
- 500 SMA
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|---|---|---|---|---|---|---|---|---|---|
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | -1.64% | 0.63% | 0.79% | -1.23% | -0.91% | -0.26% | 23.33% | 18.91% | 19.99% | 13.73% |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|---|---|---|---|
99.44% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.56% |
Equity
Name | Sector | Weight % |
---|---|---|
Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 12.29% |
Lupin Limited | Pharmaceuticals & Biotechnology | 7.26% |
Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 7.01% |
Cipla Limited | Pharmaceuticals & Biotechnology | 6.48% |
Apollo Hospitals Enterprise Limited | Healthcare Services | 5.92% |
Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | 5.91% |
Vijaya Diagnostic Centre Limited | Healthcare Services | 3.56% |
MedPlus Health Services Limited | Retailing | 3.39% |
Gland Pharma Limited | Pharmaceuticals & Biotechnology | 3.24% |
GlaxoSmithKline Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 2.99% |
Ajanta Pharma Limited | Pharmaceuticals & Biotechnology | 2.85% |
Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 2.71% |
Abbott India Limited | Pharmaceuticals & Biotechnology | 2.48% |
Dr. Lal Path Labs Limited | Healthcare Services | 2.34% |
Aurobindo Pharma Limited | Pharmaceuticals & Biotechnology | 2.27% |
Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 2.27% |
Thyrocare Technologies Limited | Healthcare Services | 2.25% |
Narayana Hrudayalaya Limited | Healthcare Services | 2.20% |
Alkem Laboratories Limited | Pharmaceuticals & Biotechnology | 2.16% |
JB Chemicals & Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 2.11% |
Biocon Limited | Pharmaceuticals & Biotechnology | 1.98% |
Pfizer Limited | Pharmaceuticals & Biotechnology | 1.98% |
Suraksha Diagnostic Limited | Healthcare Services | 1.43% |
IPCA Laboratories Limited | Pharmaceuticals & Biotechnology | 1.35% |
Torrent Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 1.35% |
Sanofi India Limited | Pharmaceuticals & Biotechnology | 1.32% |
Fortis Healthcare Limited | Healthcare Services | 1.32% |
Sanofi Consumer Healthcare India Limited | Pharmaceuticals & Biotechnology | 1.24% |
Anthem Biosciences Limited | Pharmaceuticals & Biotechnology | 0.99% |
Syngene International Limited | Healthcare Services | 0.98% |
Akums Drugs and Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 0.82% |
Emcure Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 0.74% |
AstraZeneca Pharma India Limited | Pharmaceuticals & Biotechnology | 0.70% |
Indoco Remedies Limited | Pharmaceuticals & Biotechnology | 0.66% |
Orchid Pharma Limited | Pharmaceuticals & Biotechnology | 0.43% |
Zydus Lifesciences Limited | Pharmaceuticals & Biotechnology | 0.23% |
Concord Biotech Limited | Pharmaceuticals & Biotechnology | 0.23% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV history
Date | NAV |
---|---|
20 October, 2025 | 577.1389 |
17 October, 2025 | 573.5263 |
16 October, 2025 | 572.3997 |
15 October, 2025 | 569.4740 |
14 October, 2025 | 569.3600 |
13 October, 2025 | 572.6294 |
10 October, 2025 | 572.0801 |
9 October, 2025 | 566.2688 |
8 October, 2025 | 562.1867 |
7 October, 2025 | 564.9499 |
6 October, 2025 | 563.4696 |
3 October, 2025 | 561.0231 |
1 October, 2025 | 559.2785 |
30 September, 2025 | 553.4629 |
29 September, 2025 | 555.3947 |
26 September, 2025 | 555.7762 |
25 September, 2025 | 566.9438 |
24 September, 2025 | 571.5199 |
23 September, 2025 | 575.1445 |
22 September, 2025 | 577.4076 |
19 September, 2025 | 584.3321 |
18 September, 2025 | 581.8858 |
17 September, 2025 | 578.3342 |
16 September, 2025 | 577.9610 |
15 September, 2025 | 576.6794 |
12 September, 2025 | 578.7521 |
11 September, 2025 | 576.6874 |
10 September, 2025 | 574.6801 |
9 September, 2025 | 572.5807 |
8 September, 2025 | 571.0128 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 577.1389 as on 20 October, 2025.What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -1.64% as on 20 October, 2025.What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -0.26% as on 20 October, 2025.What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 23.33% as on 20 October, 2025.What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.91% as on 20 October, 2025.What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.91% as on 20 October, 2025.